-
公开(公告)号:US20230321230A1
公开(公告)日:2023-10-12
申请号:US18190068
申请日:2023-03-24
发明人: Bowen Li , Allen Jiang , Robert S. Langer , Daniel G. Anderson
IPC分类号: A61K39/215 , C07K14/47 , A61K39/39 , C07K14/005
CPC分类号: A61K39/39 , A61K39/215 , C07K14/005 , C07K14/472 , A61K2039/53
摘要: Provided herein are, in various embodiments, methods and compositions comprising polynucleotides (e.g., mRNA) for eliciting an immune response. In certain embodiments, the disclosure provides for methods and compositions for enhancing efficacy of infectious disease treatment (e.g., mRNA vaccines). In still further embodiments, the disclosure provides methods and compositions for enhancing one or more vaccines, such as SARS-CoV-2 mRNA vaccines.
-
公开(公告)号:US11684583B2
公开(公告)日:2023-06-27
申请号:US16080737
申请日:2017-12-08
IPC分类号: A61K9/50 , C08F220/56 , A61K47/34 , A61K9/51 , A61K38/19 , A61K31/58 , A61K47/54 , A61K47/58 , A61K9/00 , C08F220/54 , C08F224/00
CPC分类号: A61K9/5052 , A61K9/0024 , A61K9/5026 , A61K9/5036 , A61K9/5169 , A61K31/58 , A61K38/193 , A61K47/34 , A61K47/54 , A61K47/58 , C08F220/54 , C08F220/56 , C08F224/00
摘要: Compositions, articles, and methods for targeted drug delivery, such as thermoresponsive hydrogel polymers, are generally provided. In one aspect, the compositions and articles comprise a thermoresponsive hydrogel polymer comprising a releasable therapeutic agent. In some cases, the compositions described herein have advantageous combinations of properties including mechanical strength, biocompatibility, tunable charge densities, thermal responsiveness, drug loading, and/or configurations for targeted drug delivery. In one embodiment, the composition comprises a solution comprising a thermoresponsive polymer including one or more ligands attached to the polymer, wherein the solution is configured to undergo a sol-to-gel transition under physiological conditions. In another embodiment, the composition comprises a plurality of nanoparticles e.g., associated with the thermoresponsive polymer. In yet another embodiment, the composition comprises a therapeutic agent e.g., associated with the nanoparticles and/or thermoresponsive polymer.
-
公开(公告)号:US20230181463A1
公开(公告)日:2023-06-15
申请号:US17925180
申请日:2021-05-14
发明人: Robert S. Langer , Carlo Giovanni Traverso , Ameya R. Kirtane , Aniket Wahane , Christina Karavasili
IPC分类号: A61K9/06 , A61K9/51 , A61K31/7052 , A61K31/7048 , A61K31/137 , A61K31/4985 , A61K47/14
CPC分类号: A61K9/06 , A61K9/5192 , A61K31/7052 , A61K31/7048 , A61K31/137 , A61K31/4985 , A61K47/14
摘要: The present disclosure provides oleogel and oleopaste compositions, as well as methods, kits, preparations, and methods of using the same. The oleogels and oleopastes presented herein include compositions comprising azithromycin, albendazole, lumefantrine, praziquantel, moxifloxacin, and ivermectin.
-
公开(公告)号:US20230101335A1
公开(公告)日:2023-03-30
申请号:US17738843
申请日:2022-05-06
摘要: An ex vivo tissue composition comprising an isolated tissue explant and tissue graft is provided. Methods of making and using the tissue composition are also provided.
-
公开(公告)号:US11547667B2
公开(公告)日:2023-01-10
申请号:US16544464
申请日:2019-08-19
申请人: Massachusetts Institute of Technology , The Brigham and Women's Hospital, Inc. , President and Fellows of Harvard College , The Children's Medical Center Corporation
发明人: Ulrich H. von Andrian , Omid C. Farokhzad , Robert S. Langer , Tobias Junt , Elliott Ashley Moseman , Liangfang Zhang , Pamela Basto , Matteo Iannacone , Frank Alexis
摘要: The present invention provides compositions and systems for delivery of nanocarriers to cells of the immune system. The invention provides vaccine nanocarriers capable of stimulating an immune response in T cells and/or in B cells, in some embodiments, comprising at least one immunomodulatory agent, and optionally comprising at least one targeting moiety and optionally at least one immunostimulatory agent. The invention provides pharmaceutical compositions comprising inventive vaccine nanocarriers. The present invention provides methods of designing, manufacturing, and using inventive vaccine nanocarriers and pharmaceutical compositions thereof. The invention provides methods of prophylaxis and/or treatment of diseases, disorders, and conditions comprising administering at least one inventive vaccine nanocarrier to a subject in need thereof.
-
公开(公告)号:US11547347B2
公开(公告)日:2023-01-10
申请号:US16152785
申请日:2018-10-05
IPC分类号: A61B5/00 , A61B5/07 , A61B5/11 , H01L41/04 , H01L41/047 , H01L41/053 , H01L41/113 , H01L41/187 , H01L41/23 , H01L41/29 , H01L41/333 , G01L1/16 , G01L19/08 , G01L9/00
摘要: Improvements in ingestible electronics with the capacity to sense physiologic and pathophysiologic states have transformed the standard of care for patients. Yet despite advances in device development, significant risks associated with solid, non-flexible gastrointestinal transiting systems remain. Here, we disclose an ingestible, flexible piezoelectric device that senses mechanical deformation within the gastric cavity. We demonstrate the capabilities of the sensor in both in vitro and ex vivo simulated gastric models, quantified its key behaviors in the GI tract by using computational modeling, and validated its functionality in awake and ambulating swine. Our piezoelectric devices can safely sense mechanical variations and harvest mechanical energy inside the gastrointestinal tract for diagnosing and treating motility disorders and for monitoring ingestion in bariatric applications.
-
公开(公告)号:US11446239B2
公开(公告)日:2022-09-20
申请号:US17024148
申请日:2020-09-17
发明人: Minglin Ma , Daniel G. Anderson , Robert S. Langer , Omid Veiseh , Joshua Charles Doloff , Delai Chen , Christian J. Kastrup , Arturo Jose Vegas
摘要: Biomedical devices for implantation with decreased pericapsular fibrotic overgrowth are disclosed. The device includes biocompatible materials and has specific characteristics that allow the device to elicit less of a fibrotic reaction after implantation than the same device lacking one or more of these characteristic that are present on the device. Biocompatible hydrogel capsules encapsulating mammalian cells having a diameter of greater than 1 mm, and optionally a cell free core, are disclosed which have reduced fibrotic overgrowth after implantation in a subject. Methods of treating a disease in a subject are also disclosed that involve administering a therapeutically effective amount of the disclosed encapsulated cells to the subject.
-
公开(公告)号:US20220257855A1
公开(公告)日:2022-08-18
申请号:US16614177
申请日:2018-05-17
发明人: Carlo Giovanni Traverso , Alex G. Abramson , Ester Caffarel Salvador , Niclas Roxhed , Minsoo Khang , Taylor Bensel , Robert S. Langer
IPC分类号: A61M5/158
摘要: Self-actuating articles including, for example, self-actuating needles and/or self-actuating biopsy punches, are generally provided. Advantageously, the self-actuating articles described herein may be useful as a general platform for delivery of a wide variety of pharmaceutical drugs that are typically delivered via injection directly into tissue due to degradation in the GI tract. The self-actuating articles described herein may also be used to deliver sensors and/or take biopsies without the need for an endoscopy. In some embodiments, the article comprises a spring (e.g., a coil spring, a beam, a material having particular mechanical recovery characteristics). Those of ordinary skill in the art would understand that the term spring is not intended to be limited to coil springs, but generally encompass any reversibly compressive material and/or component which, after releasing an applied compressive force on the material/component, the material/component substantially returns to an uncompressed length of the material/component (e.g., the within 95% of the length of the material/component prior to compression).
-
公开(公告)号:US20220202721A1
公开(公告)日:2022-06-30
申请号:US17569881
申请日:2022-01-06
发明人: Carlo Giovanni Traverso , Joshua Korzenik , Robert S. Langer , Christoph Winfried Johannes Steiger
摘要: Articles and methods for delivering a therapeutic agent to a subject are described. These articles and methods may be useful, in some cases, for the delivery of therapeutic agents to the colon of a subject. In some embodiments, an article is configured to release a secretion inducing agent e.g., to stimulate the release of intestinal fluids. The article, in some embodiments, comprises a therapeutic agent such that the stimulated release of intestinal fluid increases the amount of therapeutic agent available for absorption by the colon. For example, in some embodiments, the articles and methods described herein advantageously promote increased absorption of therapeutic agents in subjects as compared to traditionally administered therapeutic agents without additional components such as a secretion inducing agent. In some embodiments, articles and methods described herein may increase the motility of the colon of a subject. The increase in contractions and movement of fluidic in the colon caused by increase motility may advantageously facilitate the dissolution or absorption of the therapeutic agent.
-
公开(公告)号:US20220193399A1
公开(公告)日:2022-06-23
申请号:US17512156
申请日:2021-10-27
摘要: Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article may be configured such that the article may orient itself relative to a surface (e.g., a surface of a tissue of a subject). The self-righting articles described herein may comprise one 5 or more tissue engaging surfaces configured to engage (e.g., interface with, inject into, anchor) with a surface (e.g., a surface of a tissue of a subject). In some embodiments, the self-righting article may have a particular shape and/or distribution of density (or mass) which, for example, enables the self-righting behavior of the article. In certain embodiments, the self-righting article a tissuel0 interfacing components. In some embodiments, each tissue-interfacing component may comprise an electrically-conductive portion configured for electrical communication with tissue and an insulative portion configured to not be in electrical communication with tissue.
-
-
-
-
-
-
-
-
-